SAMBAI is a groundbreaking five-year research study funded by Cancer Research UK (CRUK) through the Cancer Grand Challenges initiative. Our mission is to uncover why breast, prostate, and pancreatic cancers affect people of the African diaspora at disproportionately higher rates than those of European descent.
What makes SAMBAI truly unique is its collaborative approach — bringing together world-class scientists across multiple disciplines and centering the voices of patients and communities. Together, we are redefining how cancer research is done by ensuring that those most impacted help shape the science that seeks to save their lives.